Live Breaking News & Updates on Dana Flanders|Page 5

Stay updated with breaking news from Dana flanders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Opko Health (OPK) Q4 2020 Earnings Call Transcript


Opko Health (OPK) Q4 2020 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
Opko Health (NASDAQ: OPK)
Ladies and gentlemen, thank you for standing by, and welcome to the Opko Health fourth-quarter 2020 financial results conference call. [Operator instructions] I would now like to hand the conference to speaker today, Yvonne Briggs, LHA investor relations. Please go ahead ma am.
Yvonne Briggs
LHA Investor Relations
Thank you, operator and good afternoon. This is Yvonne Briggs with LHA. Thank you all for joining today s call to discuss Opko Health financial results for the fourth quarter of 2020. I d like to remind you that any statements made during this call by management other than statements of historical fact will be considered forward-looking and as such, will be subject to risks and uncertainties that could materially affect the company s expected results. ....

United States , New York , United Kingdom , Yale Jen Laidlaw , Edward Tenthoff Piper Sandler , Mike Petusky , Steve Rubin , Phillip Frost , Yi Chen , Devin Geiman , Devin Geiman Guggenheim , Vifor Fresenius , Yale Jen , Steven Rubin , Jon Cohen , Edward Tenthoff , Piper Sandler , Maury Raycroft , Lyvonne Briggs , Charlie Bishop , Dana Flanders , Maury Raycroft Jefferies , Ministry Of Health , Nbag League , Renal Division , Yi Chen Hc Wainwright Co ,

Ligand Pharmaceuticals Inc (LGND) Q4 2020 Earnings Call Transcript


Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Ligand Pharmaceuticals Q4 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Patrick O Brien. Thank you. Please go ahead.
Patrick O Brien
Investor Relations
Thank you, Brandy. And welcome to Ligand s fourth quarter of 2020 financial results and business update conference call. All of our speakers for today s call are in separate locations. Speaking today for Ligand will be John Higgins, CEO; Matt Foehr, COO; and Matt Korenberg, CFO. We will use non-GAAP financial measures and some of our statements will be forward-looking. Additional information concerning risk factors and other matters concerning Ligand can be found in our Ligand s earning press release and our periodic filings with the SEC. Ligand undertakes no obligation to revise or update any statements to reflect events or circumstances after the date of this confe ....

United States , Matt Hewitt , Patrick Obrien , Matt Foehr , Matthew Foehr , Matt Korenberg , Balaji Prasad Barclays , John Higgins , Joe Pantginis , Balaji Prasad , Scott Henry , Dana Flanders , Matt Hewitt Craig Hallum Capital Group Analyst , Ligand Pharmaceuticals , Ligand Pharmaceuticals Inc , Jazz Pharmaceuticals , Cystic Fibrosis Foundation , Dana Flanders Guggenheim Securities , Stanford University , Joseph Pantginis Hc Wainwright Co , Vice President , Chief Financial , Analyst Day , Chief Operating , Antibody Discovery Tech , Biological Intelligence ,